Anika Therapeutics, Inc.
- ANIK
- NASDAQ
- Medical - Specialties
- Orthopedic Biologics
- Joint Preservation
- Regenerative Medicine
$19.98
Today −3.43%Quote Oct 16, 2026, 08:00 PM UTC
−4.99%over the last month
Max drawdown −9.2%From 1-month high −5.0%3 months +32.7%
Our viewPro
The call stays with Pro
Verdict, why now, and the write-up open with Pro. New accounts get 14 days of Pro free.
Market value
$267.4M
Quote Oct 16
Next earnings
Nov 4
Expected, not confirmed
Analyst target
$21.00
+5.1% from here
Floor
$19.21
3.8% below price
Where the price sits
No analyst target range for this stock.
The call stays with Pro
7 locked chapters- What to do with this namePro
- Why nowPro
- Why this stockPro
- Section write-upsPro
- Story timelinePro
- News briefPro
- Ask about ANIKPro
Verdict, why now, and the write-up open with Pro. New accounts get 14 days of Pro free.
Log in — 14 days freeWhere the money comes from
Q3 2024 revenue $38.8M
- Joint Preservation and Restoration$11.9M30.8%
- Non-Orthopedic$2.4M6.1%
- Other / not reported$24.4M63.0%
Industry
Medical - Specialties
Employees
235